Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (ACTRN12625001089426) titled 'ALLG LS27: A genomic study of lymphoma in patients with suspected inborn errors of immunity' on Oct. 7.
Study Type: Observational
Primary Sponsor: Australasian Leukaemia and Lymphoma Group
Condition:
Lymphoma
Lymphoma
Cancer - Lymphoma (non Hodgkin's lymphoma) - High grade lymphoma
Intervention:
This prospective observational study will enroll individuals with lymphoma and suspected inborn errors of immunity (IEI). A blood and saliva sample will be collected at a visit after they have been enrolled from in an initial cohort of 20 patients. Whole exome sequencing will be used to assess these samples. Phas...